| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $276,742,211 ) (Continued on the next page) |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS131658 | Single Cell Transcriptomic Profiling of Multiple System Atrophy Brain | 000 | 1 | NIH | 7/22/2024 | $666,123 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK132395 | Continuous allocation score design for guaranteeing equity and reducing discards in kidney and liver transplantation | 001 | 2 | NIH | 5/1/2024 | $41,386 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK132395 | Continuous allocation score design for guaranteeing equity and reducing discards in kidney and liver transplantation | 000 | 2 | NIH | 11/27/2023 | $620,778 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS118570 | Connecting TDP-43 Pathology to the Molecular Profiles of Neurodegeneration | 000 | 2 | NIH | 7/17/2024 | $879,816 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K02AG076883 | Cognitive prehabilitation to prevent Alzheimer's disease after kidney transplantation | 000 | 2 | NIH | 11/2/2023 | $151,740 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K02AG076883 | Cognitive prehabilitation to prevent Alzheimer's disease after kidney transplantation | 006 | 2 | NIH | 12/15/2023 | $151,740 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K02AG076883 | Cognitive prehabilitation to prevent Alzheimer's disease after kidney transplantation | 002 | 2 | NIH | 11/30/2023 | -$151,740 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL160891 | Chylomicrons and endothelial biology | 001 | 2 | NIH | 6/12/2024 | $66,231 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL160891 | Chylomicrons and endothelial biology | 000 | 2 | NIH | 12/14/2023 | $745,095 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UC2AR081039 | Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) | 002 | 3 | NIH | 6/17/2024 | $150,000 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UC2AR081039 | Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) | 002 | 3 | NIH | 6/17/2024 | -$150,000 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UC2AR081039 | Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) | 001 | 3 | NIH | 4/15/2024 | $288,149 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UC2AR081039 | Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) | 000 | 3 | NIH | 1/29/2024 | $400,000 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UC2AR081039 | Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) | 000 | 3 | NIH | 1/29/2024 | $200,000 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG075272 | Dissecting CEBPB Function with Synthetic Biology and Imaging | 001 | 3 | NIH | 5/1/2024 | $64,540 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH128311 | A translational approach for novel mechanisms of epigenetic regulation in treatment responses: toward a precision medicine model | 001 | 3 | NIH | 7/5/2024 | $69,225 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG086058 | Dissecting the aging skeletal stem cell niche | 000 | 1 | NIH | 7/18/2024 | $657,143 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG075272 | Dissecting CEBPB Function with Synthetic Biology and Imaging | 000 | 3 | NIH | 11/20/2023 | $580,863 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH128311 | A translational approach for novel mechanisms of epigenetic regulation in treatment responses: toward a precision medicine model | 000 | 3 | NIH | 12/13/2023 | $623,032 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31AI174615 | Characterization of the SARS-CoV-2-mediated piracy of p38ß | 002 | 1 | NIH | 5/9/2024 | $1,280 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31AI174615 | Characterization of the SARS-CoV-2-mediated piracy of p38ß | 001 | 1 | NIH | 11/22/2023 | $0 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA266345 | Multinuclear MRI to Monitor Breast Cancer Therapy | 001 | 2 | NIH | 4/17/2024 | $34,730 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA266345 | Multinuclear MRI to Monitor Breast Cancer Therapy | 000 | 2 | NIH | 11/13/2023 | $625,153 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AG081907 | Disruption of Endosomal Microautophagy by Pathological Tau Protein | 000 | 1 | NIH | 7/18/2024 | $211,875 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31AI174615 | Characterization of the SARS-CoV-2-mediated piracy of p38ß | 000 | 1 | NIH | 11/22/2023 | $47,694 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI176335 | Interplay between nuclear stress responses and herpesvirus latency | 001 | 1 | NIH | 3/14/2024 | $0 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH134148 | Testing multi-level scale-up strategies to implement a school-based population approach of mental health preventive intervention | 000 | 1 | NIH | 7/19/2024 | $701,406 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI176335 | Interplay between nuclear stress responses and herpesvirus latency | 000 | 1 | NIH | 11/8/2023 | $605,732 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS130035 | Impact of Schwann Cell Pathology on Axon Structure and Function | 001 | 2 | NIH | 4/11/2024 | $38,832 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32AI181496 | Investigating a RORgt-expressing antigen presenting cell required for peripheral Treg responses to gut microbiota | 000 | 1 | NIH | 7/19/2024 | $74,284 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS130035 | Impact of Schwann Cell Pathology on Axon Structure and Function | 000 | 2 | NIH | 1/24/2024 | $499,296 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA277425 | Developing new therapeutic strategies for brain metastasis | 001 | 2 | NIH | 4/16/2024 | $27,399 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA277425 | Developing new therapeutic strategies for brain metastasis | 000 | 2 | NIH | 1/5/2024 | $493,145 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA279171 | Regulation and tumorigenesis of non-classical RAS oncoproteins - Resubmission | 000 | 1 | NIH | 12/22/2023 | $543,820 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR083407 | Regulation of inflammation by the ubiquitin proteasome pathway | 000 | 1 | NIH | 1/25/2024 | $606,951 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS135884 | Benefits of Exercise on Nigrostriatal Dopamine and Motor Behavior | 000 | 1 | NIH | 12/8/2023 | $553,573 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21CA286244 | Metabolic adaptations in melanoma brain metastasis | 000 | 1 | NIH | 12/20/2023 | $198,103 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA262562 | Investigating the therapeutic potential of a novel glutamine antagonist in KEAP1 mutant lung cancer | 000 | 1 | NIH | 12/19/2023 | $672,853 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32DK136310 | Diagnosing disparities in existing and proposed allocation systems for kidney transplantation | 003 | 1 | NIH | 5/3/2024 | $4,964 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32DK136310 | Diagnosing disparities in existing and proposed allocation systems for kidney transplantation | 002 | 1 | NIH | 1/30/2024 | $0 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32DK136310 | Diagnosing disparities in existing and proposed allocation systems for kidney transplantation | 000 | 1 | NIH | 1/9/2024 | $76,292 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32DK136310 | Diagnosing disparities in existing and proposed allocation systems for kidney transplantation | 001 | 1 | NIH | 1/30/2024 | $11,500 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL171292 | EHR Nudges: Optimizing a Clinical Decision Support System for Evidence-Based Statin Medication Prescribing to Reduce the Risk of Cardiovascular Disease | 000 | 1 | NIH | 12/11/2023 | $748,424 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI176122 | Novel approach to identify RNA-bound small molecules in vivo | 001 | 2 | NIH | 5/17/2024 | $21,187 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI176122 | Novel approach to identify RNA-bound small molecules in vivo | 000 | 2 | NIH | 12/13/2023 | $190,688 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R03DE033467 | Role of autocrine cholinergic signaling in maintaining memory T cell responses in oral squamous cell carcinoma | 001 | 1 | NIH | 7/19/2024 | $0 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R03DE033467 | Role of autocrine cholinergic signaling in maintaining memory T cell responses in oral squamous cell carcinoma | 000 | 1 | NIH | 7/17/2024 | $169,500 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01EY034897 | Sensory Substitution and Brain Plasticity Following Vision Loss | 000 | 1 | NIH | 12/12/2023 | $745,798 |
| 2024 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21CA277480 | TERT epigenetic and genomic variants in stage II melanoma as biomarkers of outcome | 001 | 2 | NIH | 4/22/2024 | $9,904 |
|